The regulation on the use of supplements for weight control: Case studies from Australia, the United States of America, and the United Kingdom
secondary literature · 2025
SUMMARY
A 2025 peer-reviewed health-policy review of weight-control supplement regulation in Australia, the US, and the UK. In its UK section it reports that MHRA investigations found some diet pills contained 2,4-dinitrophenol (DNP), a poisonous substance carrying severe health risks including death, and that these findings led to the prohibition of DNP-containing products in the UK. Attached as the most recent (2025) source establishing that DNP in weight-loss/diet products remained an active regulatory concern into the mid-2020s. It documents regulatory investigation and prohibition, NOT a specific current retail listing; the routine's 2026 current-surface audit found no live sales page, so no claim of a 2026 storefront is made. Metadata (authors, journal, volume/article, DOI, PMID) read directly from the PubMed Central record https://pmc.ncbi.nlm.nih.gov/articles/PMC11905821/.
NOTES
Recent (2025) health-policy secondary source used to establish that DNP in weight-loss products remained a live regulatory concern into the mid-2020s (MHRA investigations and UK prohibition of DNP-containing products). Documents the intervention’s continued regulatory relevance into the mid-2020s; it is NOT cited for any present-day retail sales surface, which the current-surface audit did not find, and does not support a live (current/both) classification — the intervention is current_status: historical.